Annual Net Income
-$182.39 M
-$57.02 M-45.48%
December 31, 2023
Summary
- As of February 8, 2025, XENE annual net profit is -$182.39 million, with the most recent change of -$57.02 million (-45.48%) on December 31, 2023.
- During the last 3 years, XENE annual net income has fallen by -$153.56 million (-532.50%).
- XENE annual net income is now -1501.08% below its all-time high of $13.02 million, reached on December 31, 2014.
Performance
XENE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$62.79 M
-$4.87 M-8.40%
September 30, 2024
Summary
- As of February 8, 2025, XENE quarterly net profit is -$62.79 million, with the most recent change of -$4.87 million (-8.40%) on September 30, 2024.
- Over the past year, XENE quarterly net income has dropped by -$4.87 million (-8.40%).
- XENE quarterly net income is now -783.17% below its all-time high of $9.19 million, reached on September 30, 2014.
Performance
XENE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$213.39 M
-$14.33 M-7.20%
September 30, 2024
Summary
- As of February 8, 2025, XENE TTM net profit is -$213.39 million, with the most recent change of -$14.33 million (-7.20%) on September 30, 2024.
- Over the past year, XENE TTM net income has dropped by -$14.33 million (-7.20%).
- XENE TTM net income is now -1591.39% below its all-time high of $14.31 million, reached on September 30, 2014.
Performance
XENE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
XENE Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -45.5% | -8.4% | -7.2% |
| 3 y3 years | -532.5% | -32.3% | -30.3% |
| 5 y5 years | -428.7% | -32.3% | -30.3% |
XENE Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -131.2% | at low | -219.2% | at low | -170.5% | at low |
| 5 y | 5-year | -532.5% | at low | <-9999.0% | at low | -665.1% | at low |
| alltime | all time | -1501.1% | at low | -783.2% | at low | -1591.4% | at low |
Xenon Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$62.79 M(+8.4%) | -$213.39 M(+7.2%) |
| Jun 2024 | - | -$57.92 M(+20.8%) | -$199.06 M(+5.5%) |
| Mar 2024 | - | -$47.93 M(+7.1%) | -$188.60 M(+3.4%) |
| Dec 2023 | -$182.39 M(+45.5%) | -$44.74 M(-7.7%) | -$182.39 M(+4.2%) |
| Sep 2023 | - | -$48.46 M(+2.1%) | -$175.04 M(+6.9%) |
| Jun 2023 | - | -$47.46 M(+13.7%) | -$163.73 M(+11.1%) |
| Mar 2023 | - | -$41.73 M(+11.6%) | -$147.43 M(+17.6%) |
| Dec 2022 | -$125.37 M(+58.9%) | -$37.40 M(+0.7%) | -$125.37 M(+10.4%) |
| Sep 2022 | - | -$37.15 M(+19.2%) | -$113.54 M(+23.6%) |
| Jun 2022 | - | -$31.16 M(+58.4%) | -$91.84 M(+10.9%) |
| Mar 2022 | - | -$19.67 M(-23.1%) | -$82.79 M(+5.0%) |
| Dec 2021 | -$78.88 M(+173.5%) | -$25.56 M(+65.5%) | -$78.88 M(+20.2%) |
| Sep 2021 | - | -$15.45 M(-30.1%) | -$65.64 M(+11.2%) |
| Jun 2021 | - | -$22.11 M(+40.2%) | -$59.05 M(+59.1%) |
| Mar 2021 | - | -$15.76 M(+27.9%) | -$37.12 M(+28.7%) |
| Dec 2020 | -$28.84 M(-30.7%) | -$12.32 M(+39.2%) | -$28.84 M(+3.4%) |
| Sep 2020 | - | -$8.86 M(+4960.0%) | -$27.89 M(-0.1%) |
| Jun 2020 | - | -$175.00 K(-97.7%) | -$27.91 M(-26.1%) |
| Mar 2020 | - | -$7.48 M(-34.2%) | -$37.74 M(-9.3%) |
| Dec 2019 | -$41.59 M(+20.6%) | -$11.38 M(+28.2%) | -$41.59 M(+7.3%) |
| Sep 2019 | - | -$8.87 M(-11.4%) | -$38.78 M(-12.4%) |
| Jun 2019 | - | -$10.01 M(-11.8%) | -$44.29 M(+5.2%) |
| Mar 2019 | - | -$11.34 M(+32.5%) | -$42.08 M(+22.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$34.50 M(+12.4%) | -$8.56 M(-40.5%) | -$34.50 M(+1.4%) |
| Sep 2018 | - | -$14.38 M(+84.4%) | -$34.00 M(+24.3%) |
| Jun 2018 | - | -$7.80 M(+107.7%) | -$27.36 M(+1.6%) |
| Mar 2018 | - | -$3.75 M(-53.4%) | -$26.94 M(-12.3%) |
| Dec 2017 | -$30.70 M(+33.5%) | -$8.06 M(+4.2%) | -$30.70 M(+7.2%) |
| Sep 2017 | - | -$7.74 M(+4.9%) | -$28.64 M(+0.1%) |
| Jun 2017 | - | -$7.38 M(-1.8%) | -$28.61 M(+5.0%) |
| Mar 2017 | - | -$7.52 M(+25.2%) | -$27.25 M(+18.5%) |
| Dec 2016 | -$23.00 M(+46.0%) | -$6.00 M(-22.2%) | -$23.00 M(+9.9%) |
| Sep 2016 | - | -$7.71 M(+28.2%) | -$20.93 M(+22.8%) |
| Jun 2016 | - | -$6.02 M(+84.4%) | -$17.04 M(+72.9%) |
| Mar 2016 | - | -$3.26 M(-17.1%) | -$9.86 M(-37.4%) |
| Dec 2015 | -$15.75 M(-221.0%) | -$3.94 M(+2.9%) | -$15.75 M(+48.7%) |
| Sep 2015 | - | -$3.83 M(-427.7%) | -$10.59 M(-536.4%) |
| Jun 2015 | - | $1.17 M(-112.8%) | $2.43 M(-2.5%) |
| Mar 2015 | - | -$9.16 M(-848.0%) | $2.49 M(-80.9%) |
| Dec 2014 | $13.02 M(+8.2%) | $1.22 M(-86.7%) | $13.02 M(-9.0%) |
| Sep 2014 | - | $9.19 M(+647.2%) | $14.31 M(+24.5%) |
| Jun 2014 | - | $1.23 M(-10.4%) | $11.49 M(+12.0%) |
| Mar 2014 | - | $1.37 M(-45.4%) | $10.27 M(+15.4%) |
| Dec 2013 | $12.03 M(-379.7%) | $2.51 M(-60.6%) | $8.89 M(+39.4%) |
| Sep 2013 | - | $6.38 M | $6.38 M |
| Dec 2012 | -$4.30 M(-64.1%) | - | - |
| Dec 2011 | -$11.99 M | - | - |
FAQ
- What is Xenon Pharmaceuticals annual net profit?
- What is the all time high annual net income for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual net income year-on-year change?
- What is Xenon Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly net income year-on-year change?
- What is Xenon Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM net income year-on-year change?
What is Xenon Pharmaceuticals annual net profit?
The current annual net income of XENE is -$182.39 M
What is the all time high annual net income for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual net profit is $13.02 M
What is Xenon Pharmaceuticals annual net income year-on-year change?
Over the past year, XENE annual net profit has changed by -$57.02 M (-45.48%)
What is Xenon Pharmaceuticals quarterly net profit?
The current quarterly net income of XENE is -$62.79 M
What is the all time high quarterly net income for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly net profit is $9.19 M
What is Xenon Pharmaceuticals quarterly net income year-on-year change?
Over the past year, XENE quarterly net profit has changed by -$4.87 M (-8.40%)
What is Xenon Pharmaceuticals TTM net profit?
The current TTM net income of XENE is -$213.39 M
What is the all time high TTM net income for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM net profit is $14.31 M
What is Xenon Pharmaceuticals TTM net income year-on-year change?
Over the past year, XENE TTM net profit has changed by -$14.33 M (-7.20%)